Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

14.88
+0.68004.79%
Post-market: 14.77-0.1100-0.74%19:59 EDT
Volume:2.28M
Turnover:33.63M
Market Cap:2.05B
PE:-4.12
High:14.92
Open:14.40
Low:14.30
Close:14.20
52wk High:15.40
52wk Low:4.40
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.88
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:24.29
PE(LYR):-4.83

Loading ...

Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path

TIPRANKS
·
Aug 21

How COMPASS Pathways’ VA Psilocybin Trial (CMPS) Has Reframed Its Veteran Mental Health Ambitions

Simply Wall St.
·
Aug 20

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TIPRANKS
·
Aug 13

COMPASS Pathways (CMPS) Gets a Buy from Evercore ISI

TIPRANKS
·
Aug 10

Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)

TIPRANKS
·
Aug 08

Compass Pathways is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 07

Compass Pathways price target raised to $22 from $17 at B. Riley

TIPRANKS
·
Aug 06

RBC Adjusts PT on COMPASS Pathways to $21 From $22, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 06

Ireland's GH Research Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Scholar Rock Q2 Net Loss Narrows

Reuters
·
Aug 06

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

THOMSON REUTERS
·
Aug 06

Compass Pathways Grants New-Hire Inducement Equity Awards at USD 11.25 Per Share

Reuters
·
Aug 06

Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 06

Compass Pathways Plc Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing

THOMSON REUTERS
·
Aug 06

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA)

TIPRANKS
·
Aug 06

Compass Pathways PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Compass Pathways Publishes Investor Presentation on Comp360 Psilocybin Program, FDA Filing Progress and Launch Plans

Reuters
·
Aug 05

Earnings Flash (CMPS) Compass Pathways Posts Q2 Loss $1.88 a Share, vs. FactSet Est of $0.33 Loss

MT Newswires Live
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate

Benzinga Earnings
·
Aug 05